Oct 27, 2022
FDA
The new article highlights the key points related to the principles for the choice of clinical study design, such as bias and variability and the way they can affect the accuracy and reliability of the results. Table of Contents The Food and Drug Administration (FDA...
Read More
Oct 27, 2022
FDA
The new article describes in detail the aspects to be considered when identifying a medical device recall to distinguish it from other actions. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of...
Read More
Oct 21, 2022
FDA
The new article describes the types of medical devices covered by the scope of the guidance and highlights the key points to be taken into account in this respect. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in...
Read More
Oct 20, 2022
FDA
The new article describes in detail the main concepts used in the context of medical device recalls and enhancements in terms of determination of their legal nature and actions to be taken by the parties involved. Table of Contents The Food and Drug Administration...
Read More
Oct 20, 2022
FDA
The new article provides additional details regarding some of the matters related to evidence, including the benefit-risk assessment. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare...
Read More
Oct 20, 2022
FDA
The article provides a brief overview of the approach to be applied for medical device recalls and enhancements, including the determination of their regulatory nature and the requirements to be followed. Table of Contents The Food and Drug Administration (FDA or the...
Read More